Clinical trial
Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)
NCT03118037 is registered in ClinicalTrials.gov with Gynesonics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE)
- Lead sponsor
- Gynesonics
- Phase
- Observational
- Overall status
- Terminated
- Start date
- June 14, 2017
- Completion date
- November 11, 2024
- Enrollment
- 182 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
uterine fibroid